Skip to main content
. 2021 Jul 14;189(3):787–796. doi: 10.1007/s10549-021-06326-0

Table 1.

Demographic and clinical variables of participants

Variable BCC + (n = 34) BCC − (n = 32) NC (n = 35) p
Age at T1 in years (M ± SD) 49.7 ± 9.8 50.8 ± 7.1 49.6 ± 10.3 0.836
Age at T2 in years (M ± SD) 50.6 ± 9.8 52.0 ± 7.4 50.6 ± 10.2 0.777
Estimated IQ 101.3 ± 13.7 104.6 ± 12.8 107.4 ± 12.8 0.160
Educational level [n (%)]
 Low 3 (8.8) 5 (15.6) 0 (0) 0.198
 Middle 8 (23.5) 8 (25) 8 (22.8)
 High 23 (67.6) 19 (59.4) 27 (77.1)
Premenopausal [n (%)]
 T1 19 (55.9) 16 (50) 17 (48.6) 0.835
 T2 1 (2.9) 13 (40.6) 17 (48.6)  < 0.001a, b
Time between T1 and T2 (days) 332.9 ± 61.5 340.9 ± 43.4 365.3 ± 62.8 0.053
Breast cancer gradingc [n (%)]
 1 2 (5.9) 11 (34.4) 0.020b
 2 17 (50) 11 (34.4)
 3 11 (32.4) 5 (15.6)
Side of breast affected [n (%)]
 Right 12 (40) 15 (46.9) 0.300
 Left 18 (60) 13 (40.6)
Histology [n (%)]
 In-situ carcinoma 0 16 (57.1)  < 0.001b
 Invasive carcinoma 30 (100) 10 (35.7)
 Isolated tumor cells 0 2 (7.1)
Origin [n (%)]
 Ductal 28(93.3) 25(89.3) 0.078
 Lobular 2(0.07) 0
 Isolated tumor cells 0 3(0.11)
Treatment [n (%)]
 Radiotherapy 25 (73.5) 19 (59.4) 0.223
 Tamoxifen 22 (64.7) NA
Type of surgery
 Wide local excision 19 (55.9) 20 (62.5) 0.512
 Mastectomy 11 (32.2) 8 (25)
Chemotherapy complications [n (%)]
 No 20 (58.8) NA
 Yes 11 (32.4) NA
 Time since chemotherapy(days) 208.5 ± 72.0 NA

BCC + breast cancer patients receiving chemotherapy, BCC − breast cancer patients with no chemotherapy, NC non-cancer controls, IQ intelligence quotient, NART dutch version of the national adult reading test, NA not applicable

Values indicate mean ± SD unless indicated otherwise

Significance was declared by p < 0.05 and significant differences are highlighted in bold

aIndicates a significant difference between BCC + and NC

bIndicates a significant difference between BCC + and BCC − 

cGrade 1 refers to well differentiated, 2 moderately differentiated and 3 poorly differentiated